Logo image of NCNO

NCINO INC (NCNO) Stock Fundamental Analysis

USA - NASDAQ:NCNO - US63947X1019 - Common Stock

29.99 USD
-0.26 (-0.86%)
Last: 9/16/2025, 8:00:01 PM
29.99 USD
0 (0%)
After Hours: 9/16/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NCNO. NCNO was compared to 280 industry peers in the Software industry. NCNO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, NCNO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

NCNO had positive earnings in the past year.
In the past year NCNO had a positive cash flow from operations.
NCNO had negative earnings in each of the past 5 years.
In multiple years NCNO reported negative operating cash flow during the last 5 years.
NCNO Yearly Net Income VS EBIT VS OCF VS FCFNCNO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

The Return On Assets of NCNO (-1.78%) is comparable to the rest of the industry.
NCNO's Return On Equity of -2.74% is in line compared to the rest of the industry. NCNO outperforms 57.86% of its industry peers.
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROIC N/A
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
NCNO Yearly ROA, ROE, ROICNCNO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30

1.3 Margins

NCNO has a Gross Margin of 60.05%. This is in the lower half of the industry: NCNO underperforms 62.50% of its industry peers.
NCNO's Gross Margin has improved in the last couple of years.
NCNO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
NCNO Yearly Profit, Operating, Gross MarginsNCNO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

4

2. Health

2.1 Basic Checks

NCNO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NCNO has been increased compared to 1 year ago.
Compared to 5 years ago, NCNO has more shares outstanding
NCNO has a worse debt/assets ratio than last year.
NCNO Yearly Shares OutstandingNCNO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
NCNO Yearly Total Debt VS Total AssetsNCNO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

NCNO has an Altman-Z score of 3.63. This indicates that NCNO is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.63, NCNO is doing good in the industry, outperforming 62.14% of the companies in the same industry.
NCNO has a debt to FCF ratio of 5.06. This is a neutral value as NCNO would need 5.06 years to pay back of all of its debts.
NCNO has a Debt to FCF ratio of 5.06. This is comparable to the rest of the industry: NCNO outperforms 58.93% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that NCNO is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.24, NCNO perfoms like the industry average, outperforming 43.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Altman-Z 3.63
ROIC/WACCN/A
WACC10.97%
NCNO Yearly LT Debt VS Equity VS FCFNCNO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

NCNO has a Current Ratio of 1.05. This is a normal value and indicates that NCNO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.05, NCNO is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
A Quick Ratio of 1.05 indicates that NCNO should not have too much problems paying its short term obligations.
The Quick ratio of NCNO (1.05) is worse than 68.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
NCNO Yearly Current Assets VS Current LiabilitesNCNO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

6

3. Growth

3.1 Past

NCNO shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 4.41%.
NCNO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.45%.
The Revenue has been growing by 31.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)4.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)13.45%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.4%

3.2 Future

NCNO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 23.63% yearly.
NCNO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.50% yearly.
EPS Next Y10.11%
EPS Next 2Y19.92%
EPS Next 3Y23.63%
EPS Next 5YN/A
Revenue Next Year8.74%
Revenue Next 2Y8.73%
Revenue Next 3Y9.5%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NCNO Yearly Revenue VS EstimatesNCNO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
NCNO Yearly EPS VS EstimatesNCNO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 42.24, which means the current valuation is very expensive for NCNO.
NCNO's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.20. NCNO is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 31.59, the valuation of NCNO can be described as expensive.
NCNO's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. NCNO is cheaper than 62.14% of the companies in the same industry.
NCNO is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 42.24
Fwd PE 31.59
NCNO Price Earnings VS Forward Price EarningsNCNO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NCNO.
NCNO's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 67.33
EV/EBITDA 158.12
NCNO Per share dataNCNO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NCNO does not grow enough to justify the current Price/Earnings ratio.
NCNO's earnings are expected to grow with 23.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.18
PEG (5Y)N/A
EPS Next 2Y19.92%
EPS Next 3Y23.63%

0

5. Dividend

5.1 Amount

NCNO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NCINO INC

NASDAQ:NCNO (9/16/2025, 8:00:01 PM)

After market: 29.99 0 (0%)

29.99

-0.26 (-0.86%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-26 2025-08-26/amc
Earnings (Next)12-04 2025-12-04/amc
Inst Owners115.27%
Inst Owner Change0.08%
Ins Owners1.44%
Ins Owner Change20.55%
Market Cap3.47B
Analysts73.04
Price Target36.76 (22.57%)
Short Float %10.18%
Short Ratio6.52
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-19.26%
Min EPS beat(2)-36.6%
Max EPS beat(2)-1.92%
EPS beat(4)2
Avg EPS beat(4)-0.66%
Min EPS beat(4)-36.6%
Max EPS beat(4)28.46%
EPS beat(8)6
Avg EPS beat(8)20.37%
EPS beat(12)9
Avg EPS beat(12)17.38%
EPS beat(16)13
Avg EPS beat(16)21.27%
Revenue beat(2)1
Avg Revenue beat(2)-0.6%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)0.4%
Revenue beat(4)1
Avg Revenue beat(4)-0.78%
Min Revenue beat(4)-1.59%
Max Revenue beat(4)0.4%
Revenue beat(8)1
Avg Revenue beat(8)-0.95%
Revenue beat(12)3
Avg Revenue beat(12)-0.52%
Revenue beat(16)7
Avg Revenue beat(16)0.4%
PT rev (1m)12.89%
PT rev (3m)19.56%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.51%
EPS NY rev (1m)0.22%
EPS NY rev (3m)1.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)1.01%
Revenue NY rev (3m)1.12%
Valuation
Industry RankSector Rank
PE 42.24
Fwd PE 31.59
P/S 6.24
P/FCF 67.33
P/OCF 63.06
P/B 3.24
P/tB N/A
EV/EBITDA 158.12
EPS(TTM)0.71
EY2.37%
EPS(NY)0.95
Fwd EY3.17%
FCF(TTM)0.45
FCFY1.49%
OCF(TTM)0.48
OCFY1.59%
SpS4.81
BVpS9.26
TBVpS-1.47
PEG (NY)4.18
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.78%
ROE -2.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.05%
FCFM 9.27%
ROA(3y)-4.42%
ROA(5y)-4.85%
ROE(3y)-5.85%
ROE(5y)-6.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.42%
GM growth 5Y2.3%
F-Score5
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 5.06
Debt/EBITDA 11.29
Cap/Depr 9.01%
Cap/Sales 0.63%
Interest Coverage N/A
Cash Conversion 239.84%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 3.63
F-Score5
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)23.11%
Cap/Depr(5y)36.46%
Cap/Sales(3y)1.95%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y10.11%
EPS Next 2Y19.92%
EPS Next 3Y23.63%
EPS Next 5YN/A
Revenue 1Y (TTM)13.45%
Revenue growth 3Y25.44%
Revenue growth 5Y31.37%
Sales Q2Q%12.4%
Revenue Next Year8.74%
Revenue Next 2Y8.73%
Revenue Next 3Y9.5%
Revenue Next 5YN/A
EBIT growth 1Y48.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.42%
EBIT Next 3Y25.93%
EBIT Next 5YN/A
FCF growth 1Y3539%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y275.44%
OCF growth 3YN/A
OCF growth 5YN/A